Friday, May 10, 2013

• Sunesis to Present at Upcoming Investor ConferencesGlobeNewswire( (Fri, May 10)

Thursday, May 9, 2013

• Sunesis Pharmaceuticals Reports First Quarter Financial Results and Recent HighlightsGlobeNewswire( (Thu, May 9)

Thursday, May 2, 2013

• Sunesis to Host Conference Call on May 9th to Discuss First Quarter Financial Results and Recent HighlightsGlobeNewswire( (Thu, May 2)

Wednesday, April 24, 2013

• Sunesis to Present at the Needham & Company 12th Annual Healthcare ConferenceGlobeNewswire( (Wed, Apr 24)

Monday, April 8, 2013

• Over $400 Million Raised by U.S. Life Sciences Companies Through At-the-Market (ATM) Offerings in 2012, Reports Brinson PatrickPR Newswire( (Mon, Apr 8)

Thursday, March 14, 2013

• U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year PreviousMarketwired( (Thu, Mar 14)

Wednesday, March 13, 2013

• Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2012 Financial Results and Recent HighlightsGlobeNewswire( (Wed, Mar 13)

Monday, March 11, 2013

• Sunesis to Present at the 25th Annual Roth ConferenceGlobeNewswire( (Mon, Mar 11)

Wednesday, March 6, 2013

• Sunesis to Host Conference Call on March 13th to Discuss Fourth Quarter and Full-Year 2012 Financial Results and Recent HighlightsGlobeNewswire( (Wed, Mar 6)

Wednesday, February 20, 2013

• Sunesis to Present at Upcoming Investor ConferencesGlobeNewswire( (Wed, Feb 20)

Tuesday, January 29, 2013

• Major Revenue Losses From Patent Expirations Forces Big Pharma Companies to Look to the Biotech Industry for ReplacementsMarketwired( (Tue, Jan 29)

Wednesday, November 28, 2012

• Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry's Success in 2012Marketwired( (Wed, Nov 28)

Tuesday, November 20, 2012

• Sunesis to Present at the Piper Jaffray 24th Annual Healthcare ConferenceGlobeNewswire( (Tue, Nov 20)